封面
市場調查報告書
商品編碼
1325160

腫瘤切除技術的全球市場

Tumor Ablation Technologies

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年,全球腫瘤消融技術市場將達到 34 億美元

在後COVID-19改變的商業環境中,全球腫瘤切除技術市場預計2022年為13億美元,到2030年將修正為34億美元,2022年至2030年市場規模為133億美元。預計年複合成長率%。射頻消融是本報告分析的細分市場之一,預計年複合成長率為 13.7%,到分析期結束時將達到 13 億美元。鑑於疫情后的持續復甦,未來八年微波消融領域的年複合成長率將重新調整至 14.3%。

美國市場預計為3.731億美元,中國預計年複合成長率為12.3%。

到2022年,美國腫瘤切除技術市場預計將達到3.731億美元。中國作為世界第二大經濟體,預計到2030年市場規模將達到5.742億美元,2022年至2030年年複合成長率為12.3%。其他值得注意的地域市場包括日本和加拿大,預計 2022 年至 2030 年將分別成長 12% 和 11.1%。在歐洲,德國的年複合成長率預計約為 9.4%。

受訪企業示例

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • BTG International Ltd.
  • EDAP TMS SA
  • Galil Medical Ltd.
  • HealthTronics, Inc.
  • Medtronic PLC
  • Mermaid Medical A/S
  • Misonix, Inc.
  • NeuWave Medical, Inc.
  • SonaCare Medical LLC

目錄

第1章 調查方法

第2章 執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 競爭

簡介目錄
Product Code: MCP15321

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Tumor Ablation Technologies Market to Reach $3.4 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Tumor Ablation Technologies estimated at US$1.3 Billion in the year 2022, is projected to reach a revised size of US$3.4 Billion by 2030, growing at aCAGR of 13.3% over the period 2022-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is projected to record 13.7% CAGR and reach US$1.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Microwave Ablation segment is readjusted to a revised 14.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $373.1 Million, While China is Forecast to Grow at 12.3% CAGR

The Tumor Ablation Technologies market in the U.S. is estimated at US$373.1 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$574.2 Million by the year 2030 trailing a CAGR of 12.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12% and 11.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.4% CAGR.

Select Competitors (Total 46 Featured) -

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • BTG International Ltd.
  • EDAP TMS SA
  • Galil Medical Ltd.
  • HealthTronics, Inc.
  • Medtronic PLC
  • Mermaid Medical A/S
  • Misonix, Inc.
  • NeuWave Medical, Inc.
  • SonaCare Medical LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tumor Ablation Technologies - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Tumor Ablation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Tumor Ablation Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Radiofrequency Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Radiofrequency Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Radiofrequency Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Microwave Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Microwave Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Microwave Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cryoablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cryoablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Cryoablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Liver Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Tumor Ablation Technologies Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Irreversible Electroporation Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Irreversible Electroporation Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Irreversible Electroporation Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: World 16-Year Perspective for Lung Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Kidney Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Kidney Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: World 16-Year Perspective for Kidney Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2023 & 2030
  • JAPAN
    • Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2023 & 2030
  • CHINA
    • Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: China 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: China 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2023 & 2030
  • EUROPE
    • Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Tumor Ablation Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Tumor Ablation Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2023 & 2030
  • FRANCE
    • Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: France 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: France 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2023 & 2030
  • GERMANY
    • Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: Rest of World 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Rest of World Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: Rest of World 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2023 & 2030

IV. COMPETITION